Odirab 20mg Tablet contains Rabeprazole 20mg, a proton pump inhibitor (PPI) used primarily to reduce gastric acid secretion in the treatment of various acid-related gastrointestinal conditions. Rabeprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing the final step of acid production. Odirab is indicated for the management of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and peptic ulcer disease, including Helicobacter pylori eradication protocols when used in combination with appropriate antibiotics. The medication is typically administered orally once daily, preferably before meals, to optimize efficacy. Odirab 20mg is generally well-tolerated; however, patients may experience side effects such as headache, nausea, diarrhea, abdominal pain, or dizziness. Long-term use should be monitored due to potential risks including vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Caution is advised in patients with hepatic impairment, and drug interactions should be considered, particularly with medications metabolized via the cytochrome P450 system. Odirab 20mg Tablet provides effective acid suppression, promoting mucosal healing and symptom relief in acid-related disorders under appropriate medical supervision.